AYTU BIOPHARMA, INC — Director's Dealing 2016

Jul 14, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AYTU BIOSCIENCE, INC (AYTU)
CIK: 0001385818
Period of Report: 2016-07-12

Reporting Person: Cantrell Gary (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-07-12	Common Stock	A	65000	$0.00	Acquired	65000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-07-12	Stock Option Grant	$3.23	A	15000	Acquired	2026-07-12	Common Stock (15000)	Direct

Footnotes

F1: These are restricted shares that vest on July 12, 2026, subject to earlier vesting in certain situations.

F2: 25% vests on September 30, 2016, December 31, 2016, March 31, 2017 and June 30, 2017, subject to the Grantee's continued service as an employee on such dates.